Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 6;2(4):343-350.
doi: 10.1021/acsorginorgau.1c00049. eCollection 2022 Aug 3.

Mechanoenzymology in the Kinetic Resolution of β-Blockers: Propranolol as a Case Study

Affiliations

Mechanoenzymology in the Kinetic Resolution of β-Blockers: Propranolol as a Case Study

Gonzalo Gamboa-Velázquez et al. ACS Org Inorg Au. .

Abstract

Recent advances in biotechnology, protein engineering, and enzymatic immobilization have made it possible to carry out biocatalytic transformations through alternative non-conventional activation strategies. In particular, mechanoenzymology (i.e., the use of the mechanical force produced by milling or grinding to activate a biotransformation) has become a new area in so-called "green chemistry", reshaping key fundaments of biocatalysis and leading to the exploration of enzymatic transformations under more sustainable conditions. Significantly, numerous chiral active pharmaceutical ingredients have been synthesized via mechanoenzymatic methods, boosting the use of biocatalysis in the synthesis of chiral drugs. In this regard and aiming to widen the scope of the young field of mechanoenzymology, a dual kinetic resolution of propranolol precursors was explored. The biocatalytic methodology mediated by Candida antarctica Lipase B (CALB) and activated by mechanical force allowed the isolation of both enantiomeric precursors of propranolol with high enantiomeric excess (up to 99% ee), complete conversion (c = 50%), and excellent enantiodifferentiation (E > 300). Moreover, the enantiomerically pure products were used to synthesize both enantiomers of the β-blocker propranolol with high enantiopurity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Selected β-blockers sold commercially as racemic mixtures.
Figure 2
Figure 2
Mirror images of propranolol enantiomers.
Scheme 1
Scheme 1. Dual Mechanoenzymatic Kinetic Resolution via (a) Enantioselective Esterification and (b) Enantioselective Hydrolysis
Figure 3
Figure 3
Results of the evaluation of the milling-jar material. SS: stainless steel milling jar. iPrA = isopropenyl acetate.
Figure 4
Figure 4
Enzyme kinetics for the mechanoenzymatic resolution of rac-1 by enantioselective esterification. (a) Agate milling jar and balls were used. (b) Teflon milling jar and ball were used. (c) Stainless steel milling jar and ball were used.
Scheme 2
Scheme 2. Mechanoenzymatic Resolution of rac-2 via Enantioselective Hydrolysis
Scheme 3
Scheme 3. Synthetic Strategy for the Mechanosynthesis of Both Enantiomers of Propranolol

Similar articles

Cited by

References

    1. Erythropel H. C.; Zimmerman J. B.; de Winter T. M.; Petitjean L.; Melnikov F.; Lam C. H.; Lounsbury A. W.; Mellor K. E.; Janković N. Z.; Tu Q.; Pincus L. N.; Falinski M. M.; Shi W.; Coish P.; Plata D. L.; Anastas P. T. The Green ChemisTREE: 20 years after taking root with the 12 principles. Green Chem. 2018, 20, 1929–1961. 10.1039/c8gc00482j. - DOI
    1. Ardila-Fierro K. J.; Hernández J. G. Sustainability Assessment of mechanochemistry by using the twelve principles of green chemistry. ChemSusChem 2021, 14, 2145–2162. 10.1002/cssc.202100478. - DOI - PubMed
    1. Bell E. L.; Finnigan W.; France S. P.; Green A. P.; Hayes M. A.; Hepworth L. J.; Lovelock S. L.; Niikura H.; Osuna S.; Romero E.; Ryan K. S.; Turner N. J.; Flitsch S. L. Biocatalysis. Nat. Rev. Methods Primers 2021, 1, 1–46. 10.1038/s43586-021-00044-z. - DOI
    1. Gupta R. D. Recent advances in enzyme promiscuity. Sustainable Chem. Processes 2016, 4, 1–7. 10.1186/s40508-016-0046-9. - DOI
    1. Facin B. R.; Melchiors M. S.; Valério A.; Oliveira J. V.; Oliveira D. d. Driving Immobilized Lipases as Biocatalysts: 10 Years State of the Art and Future Prospects. Ind. Eng. Chem. Res. 2019, 58, 5358–5378. 10.1021/acs.iecr.9b00448. - DOI

LinkOut - more resources